Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

Page Properties
idtag

Author

  • AIDS.org

Publisher

  • AIDS.org

Category

  • Cure of AIDS

Topic

  • Antioxidants

  • Glutathione

  • NAC

Article Type

  • Editorial Article

Publish Year

  • -

Page Properties
idmeta

Meta Description

  • Stanford study shows NAC supplementation increases glutathione levels in HIV-positive volunteers, possibly reducing death risk. However, it doesn't alter HIV markers.

Summary

  • A study published in the European Journal of Clinical Investigation found that NAC (N-acetylcysteine) increased levels of an important antioxidant called glutathione in HIV-positive individuals. The study did not find any changes in viral load or immune cell counts. However, a follow-up study showed that those who took NAC had a lower risk of death compared to those who did not. The study was conducted in San Francisco and was supported by various organizations. NAC supplements will soon be available under the brand name PharmaNAC.

Meta Tag

  • NAC (N-acetylcysteine)

  • Stanford San Francisco Study

  • Glutathione

  • HIV

  • Survival Benefit

  • Consumer Labs

  • Supplements

  • European Journal of Clinical Investigation

  • PharmaNAC

  • BioAdvantex Pharma, Inc.

  • Antioxidant

  • AIDS

Featured Image

Featured Image Alt Tag

  • Keyword of the image

Disclosure: The senior authors of the NAC study reported here, Drs. LA Herzenberg, both Ph.D., of the Department of Genetics at Stanford University, are on the board of AIDS Treatment News Associates, our nonprofit arm which helps fund newsletter subscriptions for prisoners, persons with low income, and others who cannot pay for copies. The Herzenbergs have a use patent for NAC in the treatment of HIV infection, and have pledged any proceeds to further research.

...